Postpartum regulation of CRFR1 and CRFR2 expression in oxytocin neurons

催产素神经元 CRFR1 和 CRFR2 表达的产后调节

基本信息

项目摘要

Project Summary Psychological stress can profoundly impact maternal care and is associated with mental illnesses including postpartum depression and anxiety. Approximately 900,000 women suffer from postpartum depression and anxiety annually, resulting in devastating effects on the mother and developing child. Both oxytocin (OT) and corticotropin releasing factor (CRF) have been implicated in stress-related behavioral changes during the postpartum period. However, the precise mechanisms that control these changes, and the mechanisms through which the OT and CRF systems might interact to control behavioral changes, are largely unknown. We recently discovered that OT neurons of the mouse hypothalamus initiate expression of a receptor for CRF (CRFR1) during the postpartum period, whereas CRFR1 is absent from OT neurons in virgin mice. Our preliminary studies indicate the postpartum expression of CRFR1 in OT neurons modifies maternal care behaviors under conditions of stress. Our recent findings further suggest that the other primary receptor for CRF (CRFR2) also increases in OT neurons during the postpartum period. One critical issue that remains unknown is the factors that cause OT neurons to express CRF receptors. Therefore, the primary goal of this proposal (Aim 1) will be to determine the precise hormones and/or maternal experiences that induce this change. Specifically, we will treat virgin mice with pregnancy/postpartum period specific cocktails of estrogen/progesterone, prolactin, and glucocorticoids to determine the critical hormones that initiate CRFR1/CRFR2 expression in OT neurons. We will also determine whether specific experiences, including nursing and maternal care, can induce CRF receptor expression in OT neurons. Overall, experiments in Aim 1 will generate new hypotheses regarding the mechanisms through which dramatic maternal fluctuations in hormones and maternal experiences might impact the maternal brain and ultimately affect behaviors related to stress. In the second (smaller) aim we will perform a study to determine how expression of CRFR2 in OT neurons changes during the postpartum period. We recently found CRFR2 levels increase within OT neurons at a single timepoint (postpartum day 7) but how CRFR2 changes across the maternal period and whether these changes coincide temporally with alterations in CRFR1 is unknown. Therefore, this study will allow us to determine how (a) CRFR2 levels change across the postpartum period in mice and (b) whether CRFR2 and CRFR1 are present within the same OT neurons or in different subpopulations of OT neurons. These findings will be critical given that CRFR1 and CRFR2 commonly have opposing roles in regulation of stress responses and maternal behaviors. Thus, a shift in the balance of these two receptors could have profound impacts. Overall, experiments in this R03 proposal will aid in our understanding of neurobiological changes that occur during the maternal period and are associated human disorders including postpartum depression, anxiety, and poor parental care.
项目摘要 心理压力会对孕产妇护理产生深远的影响,并与精神疾病有关 产后抑郁和焦虑。大约90万妇女患有产后抑郁症和 每年焦虑,对母亲和成长中的孩子造成毁灭性影响。催产素(OT)和 皮质激素释放因子(CRF)与压力相关的行为变化有关 产后期。但是,控制这些变化的确切机制以及通过 OT和CRF系统可能会相互作用以控制行为变化,这在很大程度上未知。我们最近 发现小鼠下丘脑的OT神经元引发了CRF受体的表达(CRFR1) 在产后期间,维尔京小鼠的OT神经元不存在CRFR1。我们的初步研究 指示OT神经元中CRFR1的产后表达在条件下修饰孕妇护理行为 压力。我们最近的发现进一步表明,CRF的其他主要受体(CRFR2)也增加了 产后神经元。尚不清楚的一个关键问题是导致ot的因素 神经元表达CRF受体。因此,该提案的主要目标(AIM 1)将是确定 精确的激素和/或产妇体验会引起这种变化。具体来说,我们将对待维尔京老鼠 雌激素/孕酮,催乳素和糖皮质激素的怀孕/产后特定鸡尾酒 确定在OT神经元中启动CRFR1/CRFR2表达的临界激素。我们还将确定 特定的经验(包括护理和孕产妇护理)是否可以在OT中诱导CRF受体表达 神经元。总体而言,AIM 1中的实验将产生有关机制的新假设 激素和母性体验中产妇的戏剧性波动可能会影响母亲的大脑和 最终影响与压力有关的行为。在第二个(较小)的目标中,我们将进行一项研究以确定 OT神经元中CRFR2在产后时期的表达如何变化。我们最近发现CRFR2 在单个时间点(产后第7天),OT神经元内的水平增加 产妇时期以及这些变化是否与CRFR1的变化相吻合是未知的。 因此,这项研究将使我们能够确定(a)在产后整个产后的CRFR2水平在 小鼠和(b)CRFR2和CRFR1是否存在于相同的OT神经元内还是在不同的亚群中 OT神经元。考虑到CRFR1和CRFR2通常在 调节压力反应和孕产妇行为。因此,这两个受体的平衡可以转移 产生深远的影响。总体而言,该R03提案中的实验将有助于我们理解神经生物学 在母亲时期发生的变化,与包括产后在内的人类疾病有关 抑郁,焦虑和父母不良护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Damian Gabriel Zuloaga其他文献

Damian Gabriel Zuloaga的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Damian Gabriel Zuloaga', 18)}}的其他基金

Androgen Regulation of CRF Receptor 1 as a mediator of stress responses
雄激素对 CRF 受体 1 的调节作为应激反应的调节剂
  • 批准号:
    10724308
  • 财政年份:
    2023
  • 资助金额:
    $ 15.65万
  • 项目类别:
The role of the androgen receptor in behavior
雄激素受体在行为中的作用
  • 批准号:
    7432497
  • 财政年份:
    2007
  • 资助金额:
    $ 15.65万
  • 项目类别:
The role of the androgen receptor in behavior
雄激素受体在行为中的作用
  • 批准号:
    7230772
  • 财政年份:
    2007
  • 资助金额:
    $ 15.65万
  • 项目类别:

相似国自然基金

腹侧海马星形胶质细胞参与焦虑症发病的机制研究
  • 批准号:
    82371513
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
电针抑制AdipoR1蛋白磷酸化调控VTA相关环路功能改善焦虑症恐惧记忆障碍的机制研究
  • 批准号:
    82374254
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
高尿素通过调控REDD1/mTORC1信号通路促进慢性肾病伴发焦虑症的机制研究
  • 批准号:
    82370739
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
前额叶皮层-丘脑前核环路在焦虑症诱发记忆障碍中的作用机制及电针干预研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
外泌体miR-208-3p靶向MAPK6调控NF-κB通路参与广泛性焦虑症神经微环境炎症的作用及机制研究
  • 批准号:
    82160642
  • 批准年份:
    2021
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 15.65万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 15.65万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 15.65万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 15.65万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 15.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了